Literature DB >> 12135331

A possible mechanism for the dopamine-evoked synergistic disinhibition of thalamic neurons via the "direct" and "indirect" pathways in the basal ganglia.

I G Sil'kis1.   

Abstract

The mechanism of synaptic plasticity which we have previously proposed for striatal spiny neurons, along with published data on the predominance of dopamine-sensitive D1/D2 receptors on strionigral/striopallidal neurons, was used as the basis to propose the hypothesis that the induction of long-term potentiation/depression of the efficiency of the cortical inputs to these cells may result from the excitatory/inhibitory actions of dopamine on the activity of the neurons originating the "direct" and "indirect" pathways through the basal ganglia. Thus, the action of dopamine increases disinhibition of thalamic neurons via the "direct" pathway and decreases their inhibition via the "indirect" pathway. Both effects lead to increases in the activity of thalamic cells and in the activity of the efferent neocortical neurons which they excite. The actions of dopamine on striosomal neurons, which mainly have D1 receptors, may also be to induce long-term potentiation of cortical inputs. This effect should lead to increased inhibition of dopaminergic cells and decreases in their dopamine release, which may promote the maintenance of a stable dopamine concentration in the cortex-basal ganglia-thalamus-cortex neural network.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12135331     DOI: 10.1023/a:1015093619476

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  71 in total

1.  Inhibitory control of the GABAergic transmission in the rat neostriatum by D2 dopamine receptors.

Authors:  A Delgado; A Sierra; E Querejeta; R F Valdiosera; J Aceves
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

2.  Coactivation of D1 and D2 dopamine receptors is required for long-term synaptic depression in the striatum.

Authors:  P Calabresi; R Maj; N B Mercuri; G Bernardi
Journal:  Neurosci Lett       Date:  1992-08-03       Impact factor: 3.046

Review 3.  Disinhibition as a basic process in the expression of striatal functions.

Authors:  G Chevalier; J M Deniau
Journal:  Trends Neurosci       Date:  1990-07       Impact factor: 13.837

4.  Axonal arborizations of corticostriatal and corticothalamic fibers arising from the second somatosensory area in the rat.

Authors:  M Lévesque; S Gagnon; A Parent
Journal:  Cereb Cortex       Date:  1996 Nov-Dec       Impact factor: 5.357

Review 5.  [The structure and connections of the basal ganglia. The striatum].

Authors:  T A Leontovich; N A Mikhal'chenko
Journal:  Usp Fiziol Nauk       Date:  1997 Jan-Mar

Review 6.  Permissive role of interneurons in corticostriatal synaptic plasticity.

Authors:  D Centonze; P Gubellini; G Bernardi; P Calabresi
Journal:  Brain Res Brain Res Rev       Date:  1999-12

7.  Long-term potentiation at excitatory amino acid synapses on midbrain dopamine neurons.

Authors:  P G Overton; C D Richards; M S Berry; D Clark
Journal:  Neuroreport       Date:  1999-02-05       Impact factor: 1.837

8.  Differential interaction of competitive NMDA and AMPA antagonists with selective dopamine D-1 and D-2 agonists in a rat model of Parkinson's disease.

Authors:  P A Löschmann; U Wüllner; M T Heneka; J B Schulz; M Kunow; H Wachtel; T Klockgether
Journal:  Synapse       Date:  1997-08       Impact factor: 2.562

9.  (-)-Stepholidine acts as a D1 partial agonist on firing activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine-lesioned rats.

Authors:  B C Sun; X X Zhang; G Z Jin
Journal:  Life Sci       Date:  1996       Impact factor: 5.037

10.  Effects of full D1 dopamine receptor agonists on firing rates in the globus pallidus and substantia nigra pars compacta in vivo: tests for D1 receptor selectivity and comparisons to the partial agonist SKF 38393.

Authors:  D N Ruskin; S S Rawji; J R Walters
Journal:  J Pharmacol Exp Ther       Date:  1998-07       Impact factor: 4.030

View more
  3 in total

1.  The involvement of dopamine in strengthening cortical signals activating NMDA receptors in the striatum (a hypothetical mechanism).

Authors:  I G Sil'kis
Journal:  Neurosci Behav Physiol       Date:  2003-05

2.  A study on the mechanism by which MDMA protects against dopaminergic dysfunction after minimal traumatic brain injury (mTBI) in mice.

Authors:  S Edut; V Rubovitch; M Rehavi; S Schreiber; C G Pick
Journal:  J Mol Neurosci       Date:  2014-08-16       Impact factor: 3.444

3.  Vasoactive intestinal peptide (VIP) treatment of Parkinsonian rats increases thalamic gamma-aminobutyric acid (GABA) levels and alters the release of nerve growth factor (NGF) by mast cells.

Authors:  Orhan Tansel Korkmaz; Neşe Tunçel; Muzaffer Tunçel; Elif Mine Oncü; Varol Sahintürk; Mustafa Celik
Journal:  J Mol Neurosci       Date:  2009-12-02       Impact factor: 3.444

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.